Oncocross
Discovering drugs that can satisfy unmet needs in numerous diseases and medical conditions.
Launch date
Employees
Market cap
-
Enterprise valuation
$96m (Public information from Nov 2023)
Company register number 4828600109
Seoul South Korea (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | KRW500m | Seed |
KRW16.5b | Series B | ||
KRW23.0b | Series B | ||
* | KRW13.8b Valuation: KRW115.0b | Late VC | |
| Total Funding | $45.1m | ||
Related Content
Recent News about Oncocross
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.